Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
Clinical trial NCT01231503 · COMPLETED
Trial details
- NCT number
- NCT01231503
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-13
- Primary completion
- 2014-04-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.